Silvio Aprile - Search Results

Year	Number of Results
2007	1
2009	1
2010	3
2011	4
2012	2
2013	2
2014	2
2015	1
2016	3
2017	7
2018	5
2019	5
2020	4
2021	3
2022	1

1

Medicinal Chemistry of Isocyanides.

Massarotti A, Brunelli F, Aprile S, Giustiniano M, Tron GC. Massarotti A, et al. Among authors: aprile s. Chem Rev. 2021 Sep 8;121(17):10742-10788. doi: 10.1021/acs.chemrev.1c00143. Epub 2021 Jul 1. Chem Rev. 2021. PMID: 34197077 Free article.

2

Soft drugs for dermatological applications: recent trends.

Aprile S, Serafini M, Pirali T. Aprile S, et al. Drug Discov Today. 2019 Dec;24(12):2234-2246. doi: 10.1016/j.drudis.2019.08.007. Epub 2019 Sep 5. Drug Discov Today. 2019. PMID: 31494188 Review.

3

1,2,4-Oxadiazole-Bearing Pyrazoles as Metabolically Stable Modulators of Store-Operated Calcium Entry.

Aprile S, Riva B, Bhela IP, Cordero-Sanchez C, Avino G, Genazzani AA, Serafini M, Pirali T. Aprile S, et al. ACS Med Chem Lett. 2021 Mar 10;12(4):640-646. doi: 10.1021/acsmedchemlett.1c00034. eCollection 2021 Apr 8. ACS Med Chem Lett. 2021. PMID: 33854704 Free PMC article.

4

The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors.

Fallarini S, Bhela IP, Aprile S, Torre E, Ranza A, Orecchini E, Panfili E, Pallotta MT, Massarotti A, Serafini M, Pirali T. Fallarini S, et al. Among authors: aprile s. ChemMedChem. 2021 Nov 19;16(22):3439-3450. doi: 10.1002/cmdc.202100446. Epub 2021 Aug 27. ChemMedChem. 2021. PMID: 34355531

5

An aryne-based three-component access to α-aroylamino amides.

Serafini M, Griglio A, Viarengo S, Aprile S, Pirali T. Serafini M, et al. Among authors: aprile s. Org Biomol Chem. 2017 Aug 9;15(31):6604-6612. doi: 10.1039/c7ob01715d. Org Biomol Chem. 2017. PMID: 28752162

6

Metabolic Fate of the Isocyanide Moiety: Are Isocyanides Pharmacophore Groups Neglected by Medicinal Chemists?

Galli U, Tron GC, Purghè B, Grosa G, Aprile S. Galli U, et al. Among authors: aprile s. Chem Res Toxicol. 2020 Apr 20;33(4):955-966. doi: 10.1021/acs.chemrestox.9b00504. Epub 2020 Apr 3. Chem Res Toxicol. 2020. PMID: 32212628

7

Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors.

Aprile S, Galli U, Tron GC, Del Grosso E, Travelli C, Grosa G. Aprile S, et al. Data Brief. 2019 Dec 20;28:105034. doi: 10.1016/j.dib.2019.105034. eCollection 2020 Feb. Data Brief. 2019. PMID: 32226807 Free PMC article.

8

Store-Operated Calcium Entry as a Therapeutic Target in Acute Pancreatitis: Discovery and Development of Drug-Like SOCE Inhibitors.

Serafini M, Cordero-Sanchez C, Di Paola R, Bhela IP, Aprile S, Purghè B, Fusco R, Cuzzocrea S, Genazzani AA, Riva B, Pirali T. Serafini M, et al. Among authors: aprile s. J Med Chem. 2020 Dec 10;63(23):14761-14779. doi: 10.1021/acs.jmedchem.0c01305. Epub 2020 Nov 30. J Med Chem. 2020. PMID: 33253576 Free PMC article.

9

CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy.

Cordero-Sanchez C, Pessolano E, Riva B, Vismara M, Trivigno SMG, Clemente N, Aprile S, Ruffinatti FA, Portararo P, Filigheddu N, Zaggia I, Bhela IP, Serafini M, Pirali T, Colombo MP, Torti M, Sangaletti S, Bertoni A, Genazzani A. Cordero-Sanchez C, et al. Among authors: aprile s. Blood Adv. 2022 Jun 13:bloodadvances.2021006378. doi: 10.1182/bloodadvances.2021006378. Online ahead of print. Blood Adv. 2022. PMID: 35696753

10

Forced degradation study of thiocolchicoside: characterization of its degradation products.

Erika del G, Silvio A, Giorgio G. Erika del G, et al. Among authors: silvio a. J Pharm Biomed Anal. 2012 Mar 5;61:215-23. doi: 10.1016/j.jpba.2011.12.008. Epub 2011 Dec 17. J Pharm Biomed Anal. 2012. PMID: 22226415

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results